MediWound MDWD Stock
MediWound Price Chart
MediWound MDWD Financial and Trading Overview
| MediWound stock price | 15.99 USD |
| Previous Close | 9.88 USD |
| Open | 9.92 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 9.72 - 9.95 USD |
| 52 Week Range | 8.05 - 15.72 USD |
| Volume | 19.2K USD |
| Avg. Volume | 16.38K USD |
| Market Cap | 93.52M USD |
| Beta (5Y Monthly) | 1.042605 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.75 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34 USD |
MDWD Valuation Measures
| Enterprise Value | 25.48M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.278289 |
| PEG Ratio (5 yr expected) | -0.06 |
| Price/Sales (ttm) | 3.612434 |
| Price/Book (mrq) | 2.4862468 |
| Enterprise Value/Revenue | 0.984 |
| Enterprise Value/EBITDA | -3.258 |
Trading Information
MediWound Stock Price History
| Beta (5Y Monthly) | 1.042605 |
| 52-Week Change | 3.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.72 USD |
| 52 Week Low | 8.05 USD |
| 50-Day Moving Average | 10.76 USD |
| 200-Day Moving Average | 11.31 USD |
MDWD Share Statistics
| Avg. Volume (3 month) | 16.38K USD |
| Avg. Daily Volume (10-Days) | 14.11K USD |
| Shares Outstanding | 9.47M |
| Float | 6.05M |
| Short Ratio | 3.22 |
| % Held by Insiders | 24.23% |
| % Held by Institutions | 26.30% |
| Shares Short | 54.19K |
| Short % of Float | 0.67% |
| Short % of Shares Outstanding | 0.57% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -76.10% |
| Operating Margin (ttm) | -32.97% |
| Gross Margin | 48.40% |
| EBITDA Margin | -30.20% |
Management Effectiveness
| Return on Assets (ttm) | -11.22% |
| Return on Equity (ttm) | -111.80% |
Income Statement
| Revenue (ttm) | 25.89M USD |
| Revenue Per Share (ttm) | 4.27 USD |
| Quarterly Revenue Growth (yoy) | -13.80% |
| Gross Profit (ttm) | 13.17M USD |
| EBITDA | -7819000 USD |
| Net Income Avi to Common (ttm) | -19703000 USD |
| Diluted EPS (ttm) | -3.59 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57.2M USD |
| Total Cash Per Share (mrq) | 6.82 USD |
| Total Debt (mrq) | 743K USD |
| Total Debt/Equity (mrq) | 2.23 USD |
| Current Ratio (mrq) | 6.83 |
| Book Value Per Share (mrq) | 3.97 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7168000 USD |
| Levered Free Cash Flow (ttm) | -6509000 USD |
Profile of MediWound
| Country | United States |
| State | N/A |
| City | Yavne |
| Address | 42 Hayarkon Street |
| ZIP | 8122745 |
| Phone | 972 7 797 14100 |
| Website | https://www.mediwound.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 83 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Q&A For MediWound Stock
What is a current MDWD stock price?
MediWound MDWD stock price today per share is 15.99 USD.
How to purchase MediWound stock?
You can buy MDWD shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MediWound?
The stock symbol or ticker of MediWound is MDWD.
Which industry does the MediWound company belong to?
The MediWound industry is Biotechnology.
How many shares does MediWound have in circulation?
The max supply of MediWound shares is 9.49M.
What is MediWound Price to Earnings Ratio (PE Ratio)?
MediWound PE Ratio is now.
What was MediWound earnings per share over the trailing 12 months (TTM)?
MediWound EPS is -0.75 USD over the trailing 12 months.
Which sector does the MediWound company belong to?
The MediWound sector is Healthcare.
MediWound MDWD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}